SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits

By sjmartinez • October 11, 2022

Dixit NM, Ziaeian B, Fonarow GC. SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits. Heart Fail Clin. 2022 Oct;18(4):587-596. doi: 10.1016/j.hfc.2022.03.003. PMID: 36216488.

Tags: Cardiology/Epi, Guideline-directed medical therapy, Heart failure with preserved ejection fraction, Heart failure with reduced ejection fraction, Initiation and sequencing, Publications

Safety and T1 Reactivity for Vasodilator Stress Ferumoxytol-Enhanced Cardiac Magnetic Resonance Imaging

Pogosyan A, Keushkerian MJ, Ming Z, Mahmoudi M, Sim MS, Li Y, Finn JP, Nguyen KL. Safety and T1Reactivity for Vasodilator Stress Ferumoxytol-Enhanced Cardiac Magnetic[...]

Biological, Radiological, and Clinical Significance of Spotty Calcification in Coronary Artery Disease: A State-of-the-Art Review

Fathieh S, Gray MP, Kirkby M, Genetzakis E, Gholipour A, Poole C, Psaltis PJ, Newby DE, Douglas PS, Blankstein R, Budoff MJ, Branch K, Buckler[...]

Accessory Pathway Associated With a Venous Lake of the Right Atrial Thebesian Vein

Bharati A, Lokhandwala Y, Mori S, Back Sternick E. Accessory Pathway Associated With a Venous Lake of the Right Atrial Thebesian Vein. JACC Clin Electrophysiol.[...]